[PRISMS study. Interferon beta-1a therapy in relapsing-remitting multiple sclerosis]

Internist (Berl). 2001 Feb;42(2):305-7. doi: 10.1007/s001080050753.
[Article in German]
No abstract available

Publication types

  • Review

MeSH terms

  • Adjuvants, Immunologic / administration & dosage
  • Adjuvants, Immunologic / adverse effects
  • Adjuvants, Immunologic / therapeutic use*
  • Dose-Response Relationship, Drug
  • Double-Blind Method
  • Humans
  • Interferon-beta / administration & dosage
  • Interferon-beta / adverse effects
  • Interferon-beta / therapeutic use*
  • Multiple Sclerosis, Relapsing-Remitting / drug therapy*
  • Randomized Controlled Trials as Topic
  • Treatment Outcome

Substances

  • Adjuvants, Immunologic
  • Interferon-beta